51.91
2.81%
+1.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRNX Giù?
Forum
Previsione
Crinetics Pharmaceuticals Inc Borsa (CRNX) Ultime notizie
Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High at $51.60 - MarketBeat
MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World
Defense World
Victory Capital Management Inc. Raises Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat
MarketBeat
Where are the Opportunities in (CRNX) - Stock Traders Daily
Stock Traders Daily
Victory Capital Management Inc. Buys 139117 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
Defense World
Crinetics Pharmaceuticals (NASDAQ:CRNX) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
MarketBeat
Crinetics Pharmaceuticals executive sells $148k in company stock - Investing.com India
Investing.com India
18 Analysts Have This To Say About Crinetics Pharmaceuticals - Crinetics Pharmaceuticals (NASDAQ:CRNX) - Benzinga
Benzinga
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Stephen F. Betz Sells 3,000 Shares - MarketBeat
MarketBeat
Crinetics Pharmaceuticals, Inc. (CRNX) Shares March Higher, Can It Continue? - Yahoo News UK
Yahoo News UK
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Crinetics Pharmaceuticals (NASDAQ:CRNX) Receives “Market Outperform” Rating from JMP Securities - Defense World
Defense World
Crinetics Pharmaceuticals (NASDAQ:CRNX) Earns Buy Rating from HC Wainwright - Defense World
Defense World
Richard Scott Struthers Sells 107448 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Stock - Defense World
Defense World
Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen solid returns of 196% over the past three years - Yahoo Finance
Yahoo Finance
Crinetics Pharmaceuticals (NASDAQ:CRNX) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS - MarketBeat
MarketBeat
Crinetics Pharmaceuticals CEO sells $5.3 million in stock - Investing.com India
Investing.com India
Crinetics Pharmaceuticals' (CRNX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
MarketBeat
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
GlobeNewswire
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Crinetics Pharmaceuticals CEO sells $5.3 million in stock By Investing.com - Investing.com Australia
Investing.com Australia
Crinetics Pharmaceuticals CEO sells $5.3 million in stock By Investing.com - Investing.com
Investing.com
Crinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Results - Yahoo Finance
Yahoo Finance
Crinetics Pharmaceuticals CEO sells $5.3 million in stock - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Yahoo Finance
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update - 09.05.2024 - wallstreet:online
wallstreet:online
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update - Investing.com South Africa
Investing.com South Africa
Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High on Analyst Upgrade - Defense World
Defense World
Crinetics Pharmaceuticals Showcases Research at ENDO 2024 - TipRanks.com - TipRanks
TipRanks
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development ... - Yahoo Finance
Yahoo Finance
Crinetics Pharmaceuticals (NASDAQ:CRNX) Sets New 12-Month High on Analyst Upgrade - MarketBeat
MarketBeat
Crinetics Pharmaceuticals (CRNX) to Release Quarterly Earnings on Thursday - Defense World
Defense World
Crinetics Pharmaceuticals (NASDAQ:CRNX) Given New $97.00 Price Target at Piper Sandler - Defense World
Defense World
Is Crinetics Pharmaceuticals (CRNX) Stock a Solid Choice Right Now? - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
(CRNX) Technical Data - Stock Traders Daily
Stock Traders Daily
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Crinetics Pharmaceuticals (CRNX) Scheduled to Post Earnings on Thursday - MarketBeat
MarketBeat
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewswire
GlobeNewswire
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire Inc.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Up 6.3% in April - MarketBeat
MarketBeat
abrdn plc Purchases New Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat
MarketBeat
Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen stellar returns of 142% over the past three years - Simply Wall St
Simply Wall St
Crinetics Pharmaceuticals executive sells shares worth over $639k - Investing.com
Investing.com
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Technical Analysis of Crinetics Pharmaceuticals — TradingView News - TradingView
TradingView
Crinetics Pharmaceuticals CEO sells over $2m in company stock - Investing.com Nigeria
Investing.com Nigeria
Crinetics Pharmaceuticals Launches New Deferred Compensation Plan - TipRanks.com - TipRanks
TipRanks
Crinetics, Syndax stocks gain amid pitch at Sohn charity conference (NASDAQ:CRNX) - Seeking Alpha
Seeking Alpha
Crinetics Pharmaceuticals director sells $811,650 in stock By Investing.com - Investing.com
Investing.com
Insider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX) - Yahoo Finance
Yahoo Finance
Capitalizzazione:
|
Volume (24 ore):